Dexamethasone suppression test in patients with Parkinson's disease
Identifieur interne : 003790 ( Istex/Corpus ); précédent : 003789; suivant : 003791Dexamethasone suppression test in patients with Parkinson's disease
Auteurs : Kostić ; Nadežda Ovi Kovi Erni ; Ljiljana Besla Umbaširevi ; Gordana Oci ; Dragan Pavlovi ; Milisav NikoliSource :
- Movement Disorders [ 0885-3185 ] ; 1990.
English descriptors
Abstract
The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).
Url:
DOI: 10.1002/mds.870050106
Links to Exploration step
ISTEX:A5565DDDE3133C16F29CDC068A90E86D62965143Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title>
<author><name sortKey="Kosti" sort="Kosti" uniqKey="Kosti" last="Kosti">Kostić</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey=" Ovi Kovi Erni, Nadezda" sort=" Ovi Kovi Erni, Nadezda" uniqKey=" Ovi Kovi Erni N" first="Nadežda" last=" Ovi Kovi Erni">Nadežda Ovi Kovi Erni</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Besla Umbasirevi, Ljiljana" sort="Besla Umbasirevi, Ljiljana" uniqKey="Besla Umbasirevi L" first="Ljiljana" last="Besla Umbaširevi">Ljiljana Besla Umbaširevi</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Oci, Gordana" sort="Oci, Gordana" uniqKey="Oci G" first="Gordana" last="Oci">Gordana Oci</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pavlovi, Dragan" sort="Pavlovi, Dragan" uniqKey="Pavlovi D" first="Dragan" last="Pavlovi">Dragan Pavlovi</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Nikoli, Milisav" sort="Nikoli, Milisav" uniqKey="Nikoli M" first="Milisav" last="Nikoli">Milisav Nikoli</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A5565DDDE3133C16F29CDC068A90E86D62965143</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1002/mds.870050106</idno>
<idno type="url">https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003790</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title>
<author><name sortKey="Kosti" sort="Kosti" uniqKey="Kosti" last="Kosti">Kostić</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey=" Ovi Kovi Erni, Nadezda" sort=" Ovi Kovi Erni, Nadezda" uniqKey=" Ovi Kovi Erni N" first="Nadežda" last=" Ovi Kovi Erni">Nadežda Ovi Kovi Erni</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Besla Umbasirevi, Ljiljana" sort="Besla Umbasirevi, Ljiljana" uniqKey="Besla Umbasirevi L" first="Ljiljana" last="Besla Umbaširevi">Ljiljana Besla Umbaširevi</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Oci, Gordana" sort="Oci, Gordana" uniqKey="Oci G" first="Gordana" last="Oci">Gordana Oci</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pavlovi, Dragan" sort="Pavlovi, Dragan" uniqKey="Pavlovi D" first="Dragan" last="Pavlovi">Dragan Pavlovi</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Nikoli, Milisav" sort="Nikoli, Milisav" uniqKey="Nikoli M" first="Milisav" last="Nikoli">Milisav Nikoli</name>
<affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1990">1990</date>
<biblScope unit="vol">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="23">23</biblScope>
<biblScope unit="page" to="26">26</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A5565DDDE3133C16F29CDC068A90E86D62965143</idno>
<idno type="DOI">10.1002/mds.870050106</idno>
<idno type="ArticleID">MDS870050106</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dexamethasone suppression test</term>
<term>Parkinson's disease</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Dr. Kostić</name>
<affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string>
</affiliations>
</json:item>
<json:item><name>Nadežda Čovičković‐Šternić</name>
<affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string>
</affiliations>
</json:item>
<json:item><name>Ljiljana Beslać‐Bumbaširević</name>
<affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string>
</affiliations>
</json:item>
<json:item><name>Gordana Ocić</name>
<affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string>
</affiliations>
</json:item>
<json:item><name>Dragan Pavlović</name>
<affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string>
</affiliations>
</json:item>
<json:item><name>Milisav Nikolić</name>
<affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Dexamethasone suppression test</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<abstract>The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</abstract>
<qualityIndicators><score>2.687</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>576 x 828 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>465</abstractCharCount>
<pdfWordCount>1943</pdfWordCount>
<pdfCharCount>12626</pdfCharCount>
<pdfPageCount>4</pdfPageCount>
<abstractWordCount>62</abstractWordCount>
</qualityIndicators>
<title>Dexamethasone suppression test in patients with Parkinson's disease</title>
<genre><json:string>Serial article</json:string>
</genre>
<host><volume>5</volume>
<pages><total>4</total>
<last>26</last>
<first>23</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>1</issue>
<subject><json:item><value>Article</value>
</json:item>
</subject>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>1990</publicationDate>
<copyrightDate>1990</copyrightDate>
<doi><json:string>10.1002/mds.870050106</json:string>
</doi>
<id>A5565DDDE3133C16F29CDC068A90E86D62965143</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>1990</date>
</publicationStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title>
<author><persName><surname>Kostić</surname>
<roleName type="degree">Dr.</roleName>
</persName>
<note type="correspondence"><p>Correspondence: Neurološka klinika KCMF, ul. Dr Subotića 6, 11000 Belgrade, Yugoslavia</p>
</note>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
</author>
<author><persName><forename type="first">Nadežda</forename>
<surname>Čovičković‐Šternić</surname>
</persName>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
</author>
<author><persName><forename type="first">Ljiljana</forename>
<surname>Beslać‐Bumbaširević</surname>
</persName>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
</author>
<author><persName><forename type="first">Gordana</forename>
<surname>Ocić</surname>
</persName>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
</author>
<author><persName><forename type="first">Dragan</forename>
<surname>Pavlović</surname>
</persName>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
</author>
<author><persName><forename type="first">Milisav</forename>
<surname>Nikolić</surname>
</persName>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1990"></date>
<biblScope unit="vol">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="23">23</biblScope>
<biblScope unit="page" to="26">26</biblScope>
</imprint>
</monogr>
<idno type="istex">A5565DDDE3133C16F29CDC068A90E86D62965143</idno>
<idno type="DOI">10.1002/mds.870050106</idno>
<idno type="ArticleID">MDS870050106</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1990</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head>
<item><term>Dexamethasone suppression test</term>
</item>
<item><term>Parkinson's disease</term>
</item>
</list>
</keywords>
</textClass>
<textClass><keywords scheme="Journal Subject"><list><head>Article category</head>
<item><term>Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="1990">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="10"><doi origin="wiley" registered="yes">10.1002/mds.v5:1</doi>
<numberingGroup><numbering type="journalVolume" number="5">5</numbering>
<numbering type="journalIssue">1</numbering>
</numberingGroup>
<coverDate startDate="1990">1990</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="6" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870050106</doi>
<idGroup><id type="unit" value="MDS870050106"></id>
</idGroup>
<countGroup><count type="pageTotal" number="4"></count>
</countGroup>
<titleGroup><title type="articleCategory">Article</title>
<title type="tocHeading1">Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 1990 Movement Disorder Society</copyright>
<eventGroup><event type="firstOnline" date="2004-10-12"></event>
<event type="publishedOnlineFinalForm" date="2004-10-12"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">23</numbering>
<numbering type="pageLast">26</numbering>
</numberingGroup>
<correspondenceTo>Neurološka klinika KCMF, ul. Dr Subotića 6, 11000 Belgrade, Yugoslavia</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870050106.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="2"></count>
<count type="referenceTotal" number="28"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title>
<title type="short" xml:lang="en">DST IN PARKINSON'S DISEASE</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics>
<givenNames>Vladimir S.</givenNames>
<familyName>Kostić</familyName>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Nadežda</givenNames>
<familyName>Čovičković‐Šternić</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Ljiljana</givenNames>
<familyName>Beslać‐Bumbaširević</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Gordana</givenNames>
<familyName>Ocić</familyName>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Dragan</givenNames>
<familyName>Pavlović</familyName>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Milisav</givenNames>
<familyName>Nikolić</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="RS" type="organization"><unparsedAffiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Dexamethasone suppression test</keyword>
<keyword xml:id="kwd2">Parkinson's disease</keyword>
</keywordGroup>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Dexamethasone suppression test in patients with Parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>DST IN PARKINSON'S DISEASE</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Dexamethasone suppression test in patients with Parkinson's disease</title>
</titleInfo>
<name type="personal"><namePart type="termsOfAddress">Dr.</namePart>
<namePart type="family">Kostić</namePart>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
<description>Correspondence: Neurološka klinika KCMF, ul. Dr Subotića 6, 11000 Belgrade, Yugoslavia</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Nadežda</namePart>
<namePart type="family">Čovičković‐Šternić</namePart>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Ljiljana</namePart>
<namePart type="family">Beslać‐Bumbaširević</namePart>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Gordana</namePart>
<namePart type="family">Ocić</namePart>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Dragan</namePart>
<namePart type="family">Pavlović</namePart>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Milisav</namePart>
<namePart type="family">Nikolić</namePart>
<affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">article</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">1990</dateIssued>
<copyrightDate encoding="w3cdtf">1990</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="tables">2</extent>
<extent unit="references">28</extent>
</physicalDescription>
<abstract lang="en">The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</abstract>
<subject lang="en"><genre>Keywords</genre>
<topic>Dexamethasone suppression test</topic>
<topic>Parkinson's disease</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<subject><genre>article category</genre>
<topic>Article</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>1990</date>
<detail type="volume"><caption>vol.</caption>
<number>5</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages"><start>23</start>
<end>26</end>
<total>4</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">A5565DDDE3133C16F29CDC068A90E86D62965143</identifier>
<identifier type="DOI">10.1002/mds.870050106</identifier>
<identifier type="ArticleID">MDS870050106</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 1990 Movement Disorder Society</accessCondition>
<recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003790 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003790 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:A5565DDDE3133C16F29CDC068A90E86D62965143 |texte= Dexamethasone suppression test in patients with Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |